PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer.

Bate, J; Baker, S; Breuer, J; Chisholm, JC; Gray, J; Hambleton, S; Houlton, A; Jit, M; Lowis, S; Makin, G; +8 more... O'Sullivan, C; Patel, SR; Phillips, R; Ransinghe, N; Ramsay, ME; Skinner, R; Wheatley, K; Heath, PT; (2018) PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer. Archives of disease in childhood. ISSN 0003-9888 DOI: https://doi.org/10.1136/archdischild-2017-314212

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/archdischild-2017-314212

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar